Cargando…
ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
SIMPLE SUMMARY: ERβ, an ER subtype first identified in 1996, is significantly expressed in ERα-negative breast cancer (BCa) and TNBC. Many studies investigated mostly ERβ1 protein expression in the entire cohort of BCa, and the results are inconsistent. In this study, we simultaneously investigated...
Autores principales: | Choi, Young, Kim, Hadong, Pollack, Simcha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164084/ https://www.ncbi.nlm.nih.gov/pubmed/35723365 http://dx.doi.org/10.3390/cimb44040107 |
Ejemplares similares
-
Significant Association of Estrogen Receptor-β Isoforms and Coactivators in Breast Cancer Subtypes
por: Choi, Young, et al.
Publicado: (2023) -
Significance of ERβ expression in different molecular subtypes of breast cancer
por: Guo, Liying, et al.
Publicado: (2014) -
Molecular subtyping for clinically defined breast cancer subgroups
por: Zhao, Xi, et al.
Publicado: (2015) -
Differential expression of the BCAT isoforms between breast cancer subtypes
por: Shafei, Mai Ahmed, et al.
Publicado: (2020) -
The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer
por: Fujiwara, Saori, et al.
Publicado: (2014)